HighVista Strategies LLC - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$104,000
+103.9%
15,000
+40.2%
0.09%
+83.0%
Q1 2020$51,000
-45.2%
10,7000.0%0.05%
-33.8%
Q4 2019$93,000
+52.5%
10,700
-41.5%
0.07%
+69.0%
Q3 2019$61,00018,3000.04%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 1,347,829$9,152,00093.42%
Ally Bridge Group (NY) LLC 550,000$3,735,0002.77%
ACUTA CAPITAL PARTNERS, LLC 813,500$5,524,0002.58%
TRV GP III, LLC 1,148,780$7,800,0002.12%
Deep Track Capital, LP 4,259,653$28,923,0001.86%
Logos Global Management LP 1,400,000$9,506,0001.23%
PFM Health Sciences, LP 3,972,868$26,976,0001.01%
Sofinnova Investments, Inc. 1,481,219$10,057,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 248,347$1,686,0000.70%
RTW INVESTMENTS, LP 4,680,412$31,780,0000.66%
View complete list of JOUNCE THERAPEUTICS INC shareholders